Evidence map›Paper›PMID 26074923›Full record

ReviewFrontiers in immunology2015

Much More than M1 and M2 Macrophages, There are also CD169(+) and TCR(+) Macrophages.

Leslie Chávez-Galán, Maria L Olleros, Dominique Vesin, Irene Garcia

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 427 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
427citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

427 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Type I interferon-induced CD169Journal of periodontology · 2026
    Article
  8. Review
  9. METTL3-mCurrent medical science · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. A 62-aa core of the cochlin LCCL domain induces macrophage M1 polarization in vitro.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  17. Review
  18. Suppression of cardiac allograft vasculopathy by a macrophage efferocytosis receptor.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  19. Review
  20. Article

367 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Leslie Chávez-GalánDepartment of Pathology and Immunology, Faculty of Medicine, Centre Medical Universitaire (CMU), University of Geneva , Geneva , Switzerland ; Laboratory of Integrative Immunology, National Institute of Respiratory Diseases Ismael Cosio Villegas , Mexico City , Mexico.
Maria L OllerosDepartment of Pathology and Immunology, Faculty of Medicine, Centre Medical Universitaire (CMU), University of Geneva , Geneva , Switzerland.
Dominique VesinDepartment of Pathology and Immunology, Faculty of Medicine, Centre Medical Universitaire (CMU), University of Geneva , Geneva , Switzerland.
Irene GarciaDepartment of Pathology and Immunology, Faculty of Medicine, Centre Medical Universitaire (CMU), University of Geneva , Geneva , Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monocytes are considered to be precursor cells of the mononuclear phagocytic system, and macrophages are one of the leading members of this cellular system. Macrophages play highly diverse roles in maintaining an organism's integrity by either directly participating in pathogen elimination or repairing tissue under sterile inflammatory conditions. There are different subpopulations of macrophages and each one has its own characteristics and functions. In this review, we summarize present knowledge on the polarization of macrophages that allows the generation of subpopulations called classically activated macrophages or M1 and alternative activated macrophages or M2. Furthermore, there are macrophages that their origin and characterization still remain unclear but have been involved as main players in some human pathologies. Thus, we also review three other categories of macrophages: tumor-associated macrophages, CD169(+) macrophages, and the recently named TCR(+) macrophages. Based on the literature, we provide information on the molecular characterization of these macrophage subpopulations and their specific involvement in several human pathologies such as cancer, infectious diseases, obesity, and asthma. The refined characterization of the macrophage subpopulations can be useful in designing new strategies, supplementing those already established for the treatment of diseases using macrophages as a therapeutic target.

Indexed as

M1/M2 polarizationmacrophagesmonocytespathologiesTAM generation

Identifiers

PMID26074923
PMCPMC4443739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.